Skip to content
Skip to footer

Back to McKesson.com Home

Business Services and Solutions

Our integrated approach combines expert advisory services and cutting-edge technology to help you overcome challenges, identify opportunities, and improve your pharmacy’s performance.

Explore
- Professional & Advisory Services
  
  Improve your pharmacy's business performance with McKesson's Professional & Advisory Services (P&AS). By leveraging deep industry knowledge and advanced analytics, we help you improve operations so you can achieve more for the business of pharmacy.
  
  Specialty and Infusion Solutions for Health Systems
  
  Specialty Pharmacy
  
  Payer Solutions
  
  340B Advisory
  
  340B Impact
  
  Contract Concierge
  
  Orphan Drug Support Program
- Additional Business Solutions
  
  Our extensive portfolio of business solutions empowers health system pharmacies to achieve more by improving operations and driving business growth. Leveraging technology-driven platforms and strategic guidance, we provide actionable insights to address critical challenges, including supply chain management, revenue cycle optimization, 340B drug pricing, and more.
  
  Macro Helix™/ RxO
  
  Class of Trade Optimization
  
  SupplyLogix®
  
  EnterpriseRx®
Pharmaceutical Products and Distribution

It's time to expect more from your pharmaceutical distributor. Let us provide the perspective, focus, and execution you need to help the business of pharmacy achieve more for the advancement of patient health. Our innovative distribution strategies and suite of pharmaceutical products empower your health system to focus on your commitment on advancing value-based care.

Explore
- Pharmaceutical Products
  
  Our expansive portfolio is designed to support the continuum of care, from groundbreaking biosimilar innovations and essential generics to life-changing orphan drugs and revolutionary cell and gene therapies. Additionally, our robust supply assurance strategies ensure that you can depend on a consistent and timely delivery of the medications your patients rely on.
  
  Biosimiliars
  
  Branded and Generic Products
  
  Orphan Drugs
  
  Cell, Gene, & Advanced Therapies
  
  Supply Assurance
- McKesson Plasma & Biologics
  
  As demand for specialty pharmaceuticals and biologics continues to rise and add complexity to the supply chain, we’re responding with new distribution strategies to seamlessly deliver. McKesson Plasma and Biologics offers customers an expansive portfolio of plasma-derived products, biologics and other specialty drugs at competitive prices from a single source that has deep experience in specialized patient care. 
- Ordering and Reporting
  
  McKesson's innovative ordering and reporting solutions are designed to help health systems achieve more for the business of pharmacy. Our comprehensive platforms allow your pharmacy to streamline operations, optimize inventory and make data-driven decisions.
  
  McKesson Enterprise Reporting & Analytics (ERA)
  
  Connect Ordering
  
  Rapid Returns
Industry News and Insights

Staying informed on the latest industry news and insights is critical in achieving more for the business of pharmacy. Within Prescribed Perspectives, you’ll find exclusive articles, podcasts, eBooks, research, and additional resources authored by our health system experts that can help your health system pharmacy with operational efficiency, cost-saving strategies, and more.

Explore
- Prescribed Perspectives Insights Center
  
  A dedicated resource for health system teams to access valuable industry insights and cost-saving strategies.
  
  Research
  
  Case Studies
  
  eBooks
  
  Industry Webinars
  
  View All
  
  Subscribe Now
- Our Authors
  
  With unique industry knowledge and first-hand experience across virtually all areas of health system pharmacy, our authors and experts are dedicated to helping you achieve more.
- Insights by Topic
  
  Get straight to the insights that matter most to your health system.
  
  C-Suite Considerations
  
  340B
  
  Specialty Pharmacy
  
  Supply Chain & Distribution
  
  MHS in the News
  
  View All
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.
Contact Health Systems

Ready to achieve more for the business of pharmacy? Contact us today to discover how McKesson's innovative business services and solutions can help improve your operations and drive financial success.

Contact Us Now
- Contact Health Systems
  
  Contact Us
  
  Communications Preference Center
- Industry Conferences and Events
  
  Join us at upcoming healthcare and pharmacy conferences to connect with our industry-leading experts, gain valuable insights, discover innovative solutions, and participate in strategic discussions that advance the future of health system pharmacy.

Good News for Biosimilar Adoption Rates as Pharmacies Find Workable Strategies

Navigating the use of biosimilars with the 340B Drug Pricing Program.

By McKesson Health Systems Editorial Team

Date

January 11, 2022

By: Heather Easterling

Read time: 7 minutes

After a slow start, biosimilar adoption rates are trending upward in the United States. According to AmGen, there was a 65% increase in the number of approved biosimilars between 2019-2020 and a 157% increase in available biosimilars in the U.S.

An expert from our 340B Solutions team explains what these biosimilar adoption rates mean for 340B-qualified pharmacies.

Learn more about navigating the use of biosimilars with the 340B Drug Pricing Program.

Related Stories

Close-up of an IV drip chamber with clear fluid flowing through tubing, with gloved hands and a clinical setting in the background.

Inside the Growth of Infusion Care: What’s Driving Demand—and How Health Systems Can Keep Pace

Empowering health systems to expect more from their infusion programs—and achieve more for every patient.

Person in a white lab coat holding a clipboard while standing near shelves of medical supplies.

Can You Answer These 10 Questions About Your Health System’s Specialty Pharmacy?

This interactive checklist guides you through 10 critical questions that can help uncover next steps for your health system’s specialty pharmacy strategy.

Infusion checklist with steps for preparation, administration, and monitoring displayed in a table format.

Do You Have a Plan to Modernize Your Infusion Strategy?

This interactive checklist guides you through 5 critical questions that can help uncover next steps for your health system’s infusion service line.

Abstract geometric shapes in blue and pink tones with a glass-like effect.

Event Preview: An Exclusive Look at McKesson’s Industry Experts and Insights You’ll Find at the 2025 ASHP Midyear Meeting

Take a look at the industry insights, experience, and expertise you’ll have access to at this year’s ASHP Midyear.

Close-up of a professional microphone in a shock mount with a blurred computer screen in the background.

Podcast: What Does a Successful Infusion Strategy Really Look Like for Health Systems?

McKesson’s Intrafusion expert discusses the measurable impacts of a successful infusion service line in health systems.

Interactive 340B and IRA Resource Library text on a background with light blue and yellow geometric shapes.

Stay Informed on the Evolving 340B and IRA Landscape

Use this comprehensive library of resources to find important information on what’s changing with 340B and IRA, when, and why it may matter for your health system pharmacy.

A hand holds a magnifying glass with a blue medical cross, focusing on a search bar in a blurred office or hospital background.

8 Insights to Impact Your Specialty Pharmacy Strategy

An interactive experience highlighting key insights for success across 8 domains of specialty pharmacy.

Two people in white lab coats work in a pharmacy with shelves of medications behind them. One writes on a clipboard, while the other examines a bottle.

A Successful Health System Pharmacy Strategy Starts with Access to These Three Things

One of our Specialty Pharmacy Enablement (SPE) experts outlines her three-pronged approach for success and suggests the addition of a critical fourth.

Checklist: 5 Questions to Ask When Evaluating Next Steps for Your Health System’s Infusion Strategy on blue background with checkmarks.

Checklist: 5 Questions to Ask When Evaluating Next Steps for Your Health System’s Infusion Strategy

Download this checklist for an at-a-glance view of important considerations when modernizing your health system’s infusion service line.

A yellow arrow passes through four blue doors in a row, all set against a blue background.

Podcast: Solving for Access in the Health System Specialty Pharmacy – and Why It Matters

Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.

Related Tags

Related Tags